CinCor Pharma Stock Surges on Offer to Be Obtained by AstraZeneca
AstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 billion, the British pharmaceutical ...
Read moreDetailsAstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 billion, the British pharmaceutical ...
Read moreDetailsShares of Voyager Therapeutics Inc. VYGR, +10.65% rallied 35% in premarket buying and selling on Monday soon after the corporation ...
Read moreDetailsWe've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We've detected ...
Read moreDetailsAstraZeneca agreed to invest in U.S. biotech enterprise CinCor Pharma in a offer perhaps valued at $1.8 billion, the British ...
Read moreDetailsMy 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to have to determine out ...
Read moreDetailsGE’s Spinoff Warrants Healthy Skepticism
Read moreDetailsMy 2023 biotech outlook calls for ongoing momentum in title variations. I just will need to determine out what the ...
Read moreDetailsAbbVie Inc. executives decreased their outlook for the quarter and yr in a filing with the Securities and Exchange Commission ...
Read moreDetailsPfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include the development of new ...
Read moreDetailsWalgreens Income Drop as Demand for Covid Vaccines Wanes
Read moreDetailsEmail Contact: souhaib@trendswide.com